APOE Gene Drives Over 90% of Alzheimer’s Cases – New Study Reveals
A new analysis led by researchers at University College London suggests that alzheimer’s disease may depend far more on one gene than previously recognized. The study estimates that more than 90% of Alzheimer’s cases might not develop without the influence of a single gene called APOE.
The researchers also found that the gene’s impact extends beyond Alzheimer’s alone. Their analysis indicates that nearly half of all dementia cases may also rely on APOE’s contribution.
Published in npj Dementia, the findings point to APOE and the protein it produces as a major yet often overlooked target for drug development. Targeting this gene could open the door to preventing or treating a large share of dementia cases worldwide.
Understanding the APOE gene and Its Variants
Scientists have known for decades that APOE is linked to Alzheimer’s disease. The gene comes in three common forms, or alleles, called ε2, ε3, and ε4. Each person carries two copies of the gene,which results in six possible combinations of these variants.
Research dating back to the 1990s showed that people who carry one or two copies of the ε4 variant face a much higher risk of developing Alzheimer’s compared with those who inherit two ε3 copies. By contrast, people with ε2 generally have a lower risk than ε3 carriers.
Why Scientists Say APOE’s Role Has Been Underestimated
Lead author Dr. Dylan Williams (UCL Division of Psychiatry and Unit for Lifelong Health and Ageing at UCL) saeid: ”We have long underestimated how much the APOE gene contributes to the burden of Alzheimer’s disease. the ε4 variant of APOE is well recognized as harmful by dementia researchers, but much disease would not occur without the additional impact of the common ε3 allele, which has been typically misperceived as neutral in terms of Alzheimer’s risk.
“When we consider the contributions of ε3 and ε4, we can see that APOE perhaps has a role in almost all Alzheimer’s disease. Consequently, if we knew how to reduce the risk that the ε3 and ε4 variants confer to people, we might potentially be able prevent most disease from occurring.”
The Largest modeling Study of APOE’s Population Impact
This research represents the most comprehensive modeling effort so far to estimate how many Alzheimer’s and dementia cases across the population are tied to common APOE variants. The team combined evidence linking ε3 and ε4 to Alzheimer’s, broader dementia diagnoses, and the brain changes that precede the disease.
A key strength of the analysis was access to data from four very large studies, totaling more than 450,000 participants. this allowed researchers to identify a sizable group of people with two ε2 copies, an uncommon but low risk group, and use them as a baseline for comparison for the first time in this type of study.
How Much Alzheimer’s and Dementia May Depend on APOE
Using this approach, the researchers estimated that between 72% and 93% of Alzheimer’s cases would not have occurred without the ε3 and ε4 variants of APOE.they also concluded that about 45% of all dementia cases may rely on the gene’s influence.
These figures are higher than earlier estimates of APOE’s role, largely as this analysis accounted for the effects of both ε3 and ε4 rather than focusing on ε4 alone.
Why Results Differed Across Studies
The four studies included in the analysis did not all produce identical results. Differences arose from how Alzheimer’s and dementia were defined and measured, such as whether diagnoses were based on medical records, other dementia classifications, or amyloid buildup seen in brain scans. Variation in follow-up time and recruitment methods also played a role.